About Conference

The 18th International Conference on Neurology and Neuromuscular Disorders will take place on February 16–17, 2026, in Paris, France, serving as a premier global platform for the exchange of advanced knowledge in the field of neurology. This distinguished scientific event will convene leading neurologists, neuroscientists, clinicians, and academic professionals to explore transformative developments in neurology and neuromuscular science.

Guided by the theme “Neurogenomics and Neurorestoration: Bridging Precision Medicine and Motor Recovery in Neurology and Neuromuscular Disorders,” the conference will spotlight the convergence of genomic technologies and restorative neuroscience. Discussions will center on innovations in neurogenetic diagnostics, gene-targeted therapies, neuroregenerative strategies, and the application of precision medicine to enhance motor function and clinical outcomes.

Neurology Conference 2026 offers an exceptional opportunity to engage with cutting-edge research, participate in high-impact scientific sessions, and foster international collaborations that are driving the next generation of neurological care. With a dynamic program featuring keynote addresses, expert panels, symposia, and interactive workshops, this event is poised to shape the future trajectory of neurology and neuromuscular therapeutics.

Join us in the heart of Paris for an inspiring and intellectually enriching experience at the forefront of neurological science.

Why Attend the Conference?

The 18th International Conference on Neurology and Neuromuscular Disorders (Neurology Conference 2026), scheduled for February 16–17, 2026, in Paris, France, is a premier global gathering designed to foster high-impact scientific exchange, interdisciplinary collaboration, and clinical innovation in the field of neurology. Under the theme “Neurogenomics and Neurorestoration: Bridging Precision Medicine and Motor Recovery in Neurology and Neuromuscular Disorders,” the conference offers a uniquely enriching experience for all participants.

For Keynote Speakers and Presenters:
Gain international visibility by presenting to a distinguished audience of peers, decision-makers, and industry leaders. Enhance your academic profile and contribute to shaping the scientific dialogue on next-generation neurology and neuromuscular therapeutics.

For Delegates and Clinicians:
Access cutting-edge research, translational case studies, and evidence-based clinical updates. Participate in advanced scientific sessions and expert-led discussions that can directly inform your practice and research priorities.

For Young Investigators and Students:
Receive mentorship from senior scientists, participate in exclusive career development sessions, and compete for young researcher recognition awards. Present your research in a globally respected forum and gain critical exposure early in your career.

For Exhibitors and Sponsors:
Position your brand at the forefront of neurological innovation. Engage with a highly specialized audience, build strategic alliances, and showcase breakthrough technologies and solutions in neurology, diagnostics, and therapeutics.

For All Attendees:
Network with global thought leaders, explore collaborative research and funding opportunities, and gain actionable insights into the future of precision neurology and neurorehabilitation. Set in the vibrant scientific and cultural hub of Paris, this conference is a strategic investment in your professional growth and institutional advancement.

Who Can Attend?

• Neurologists

• Neuroscientists

• Neurosurgeons

• Neuromuscular Specialists

• Neurogeneticists

• Physiatrists

• Neurorehabilitation Experts

• Clinical Researchers

• Academic Faculty

• Medical and Healthcare Professionals

• Pharmaceutical and Biotech Scientists

• Medical Device and Neurotechnology Developers

• Postdoctoral Fellows

• PhD Scholars

• Graduate and Medical Students

• Hospital Administrators

• Rehabilitation Center Directors

• Public Health Officials

• Healthcare Policy Makers

• Industry Experts

• Sponsors and Exhibitors

• Research Institutions and Laboratories

• Scientific Societies and Associations

Market Analysis Report

The global market for neurology and neuromuscular disorders is witnessing unprecedented growth, driven by rapid advancements in neurogenomics, digital health technologies, and increasing patient awareness. As of 2025, Europe and other developed regions stand at the forefront of this expansion due to strong healthcare infrastructure, an aging population, and significant R&D investments.

In Europe, the digital health in neurology sector is projected to reach USD 37.09 billion by 2030, growing at a CAGR of 22.7% from 2024 onward. Germany, the UK, and France are leading contributors, fueled by increased adoption of AI-based diagnostic tools and remote monitoring systems.

The neurology devices market in Europe was valued at USD 3.73 billion in 2023, and is expected to grow to USD 6.43 billion by 2030, at a CAGR of 8.1%. Devices supporting neurostimulation and neurorestoration represent the fastest-growing segments.

Globally, the digital health in neurology market reached USD 34.3 billion in 2023 and is set to expand at a CAGR of over 19% through 2032, driven by rising neurological disorder prevalence and the shift toward personalized medicine.

These trends highlight significant opportunities for researchers, clinicians, and industry partners to collaborate, innovate, and invest in next-generation neurotherapeutics.